Artigos de revistas sobre o tema "ETS fusions"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "ETS fusions".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Smith, Jenny L., Rhonda E. Ries, Yi-Cheng Wang, Amanda R. Leonti, Todd A. Alonzo, Alan S. Gamis, Richard Aplenc et al. "ETS Family Transcription Factor Fusions in Childhood AML: Distinct Expression Networks and Clinical Implications". Blood 138, Supplement 1 (5 de novembro de 2021): 2356. http://dx.doi.org/10.1182/blood-2021-148894.
Texto completo da fonteBarbi de Moura, Michelle, Fadel S. Alyaqoub, Gargi D. Basu, David W. Hall, Jess R. Hoag, Janine R. LoBello, Frederick L. Baehner, Snehal Govind Thakkar e Steven Canfield. "Erythroblast transformation-specific transcription factor fusions in prostate cancer." Journal of Clinical Oncology 41, n.º 6_suppl (20 de fevereiro de 2023): 224. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.224.
Texto completo da fonteStaege, Martin S., e Daniela Max. "Genetics and Epigenetics of the TET-ETS Translocation Network". Genetics & Epigenetics 2 (janeiro de 2009): GEG.S2815. http://dx.doi.org/10.4137/geg.s2815.
Texto completo da fonteWei, Ting, Ji Lu, Tao Ma, Haojie Huang, Jean-Pierre Kocher e Liguo Wang. "Re-Evaluate Fusion Genes in Prostate Cancer". Cancer Informatics 20 (janeiro de 2021): 117693512110275. http://dx.doi.org/10.1177/11769351211027592.
Texto completo da fonteGasi Tandefelt, Delila, Joost Boormans, Karin Hermans e Jan Trapman. "ETS fusion genes in prostate cancer". Endocrine-Related Cancer 21, n.º 3 (20 de março de 2014): R143—R152. http://dx.doi.org/10.1530/erc-13-0390.
Texto completo da fonteAnderson, Nathaniel D., Richard de Borja, Matthew D. Young, Fabio Fuligni, Andrej Rosic, Nicola D. Roberts, Simon Hajjar et al. "Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors". Science 361, n.º 6405 (30 de agosto de 2018): eaam8419. http://dx.doi.org/10.1126/science.aam8419.
Texto completo da fonteButeyn, Nathaniel J., Connor Burke, Eve Gardner, Vincent J. Sartori, Rhonda E. Ries, Todd A. Alonzo, Soheil Meshinchi e Timothy Triche. "Reclassification of ETS Family Transcription Factor Fusions in Pediatric AML Based on Molecular Drivers". Blood 142, Supplement 1 (28 de novembro de 2023): 4298. http://dx.doi.org/10.1182/blood-2023-189474.
Texto completo da fonteLawlor, E. R., J. A. Mathers, T. Bainbridge, D. E. Horsman, A. Kawai, J. H. Healey, A. G. Huvos, J. A. Bridge, M. Ladanyi e P. H. Sorensen. "Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis." Journal of Clinical Oncology 16, n.º 3 (março de 1998): 1150–57. http://dx.doi.org/10.1200/jco.1998.16.3.1150.
Texto completo da fonteDowning, Nicholas F., Kaitlyn M. Mills e Peter C. Hollenhorst. "Abstract 3033: Oncogenic ETS transcription factors avoid repression by EZH2 and FOXO1 in prostate cancer and Ewing sarcoma". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 3033. http://dx.doi.org/10.1158/1538-7445.am2024-3033.
Texto completo da fonteClark, Jeremy P., e Colin S. Cooper. "ETS gene fusions in prostate cancer". Nature Reviews Urology 6, n.º 8 (agosto de 2009): 429–39. http://dx.doi.org/10.1038/nrurol.2009.127.
Texto completo da fonteDeneen, Benjamin, Scott M. Welford, Thu Ho, Felicia Hernandez, Irwin Kurland e Christopher T. Denny. "PIM3 Proto-Oncogene Kinase Is a Common Transcriptional Target of Divergent EWS/ETS Oncoproteins". Molecular and Cellular Biology 23, n.º 11 (1 de junho de 2003): 3897–908. http://dx.doi.org/10.1128/mcb.23.11.3897-3908.2003.
Texto completo da fonteMani, Ram-Shankar, Scott A. Tomlins, Kaitlin Callahan, Aparna Ghosh, Mukesh K. Nyati, Sooryanarayana Varambally, Nallasivam Palanisamy e Arul M. Chinnaiyan. "Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer". Science 326, n.º 5957 (29 de outubro de 2009): 1230. http://dx.doi.org/10.1126/science.1178124.
Texto completo da fonteHussain, Maha, Stephanie Daignault-Newton, Przemyslaw W. Twardowski, Costantine Albany, Mark N. Stein, Lakshmi P. Kunju, Javed Siddiqui et al. "Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012". Journal of Clinical Oncology 36, n.º 10 (1 de abril de 2018): 991–99. http://dx.doi.org/10.1200/jco.2017.75.7310.
Texto completo da fonteZhang, Yue. "Article Commentary: ETS-FUSions Networking, Triggering and Beyond". Genetics & Epigenetics 3 (janeiro de 2010): GEG.S4166. http://dx.doi.org/10.4137/geg.s4166.
Texto completo da fonteFeng, Felix Y., J. Chad Brenner, Maha Hussain e Arul M. Chinnaiyan. "Molecular Pathways: Targeting ETS Gene Fusions in Cancer". Clinical Cancer Research 20, n.º 17 (23 de junho de 2014): 4442–48. http://dx.doi.org/10.1158/1078-0432.ccr-13-0275.
Texto completo da fonteZou, Ying S., Laura Morsberger, Melanie Hardy, Jen Ghabrial, Victoria Stinnett, Jaclyn B. Murry, Patty Long et al. "Complex/cryptic EWSR1::FLI1/ERG Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas". Genes 14, n.º 6 (24 de maio de 2023): 1139. http://dx.doi.org/10.3390/genes14061139.
Texto completo da fonteYoshimoto, M., A. M. Joshua, S. Chilton-Macneill, J. Bayani, M. Prasad, N. Fleshner, A. Finelli et al. "Detection of novel variant TMPRSS2 /ERG fusion transcripts suggests independent genomic alterations may underlie origin of multi-centric prostate cancer". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junho de 2006): 10029. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10029.
Texto completo da fonteHe, Wei, Fukang Sun, Juping Zhao, Dai Jun, Le Xu, Chenghe Wang, Chen Fang et al. "Prevalence and genetic features of TMPRSS2-ERG fusion in Chinese patients with prostate cancer." Journal of Clinical Oncology 38, n.º 15_suppl (20 de maio de 2020): e17529-e17529. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e17529.
Texto completo da fonteArvand, Afsane, e Christopher T. Denny. "Biology of EWS/ETS fusions in Ewing's family tumors". Oncogene 20, n.º 40 (setembro de 2001): 5747–54. http://dx.doi.org/10.1038/sj.onc.1204598.
Texto completo da fonteKhosh Kish, Ealia, Muhammad Choudhry, Yaser Gamallat, Sabrina Marsha Buharideen, Dhananjaya D e Tarek A. Bismar. "The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer". International Journal of Molecular Sciences 23, n.º 9 (26 de abril de 2022): 4772. http://dx.doi.org/10.3390/ijms23094772.
Texto completo da fonteKhosh Kish, Ealia, Muhammad Choudhry, Yaser Gamallat, Sabrina Marsha Buharideen, Dhananjaya D e Tarek A. Bismar. "The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer". International Journal of Molecular Sciences 23, n.º 9 (26 de abril de 2022): 4772. http://dx.doi.org/10.3390/ijms23094772.
Texto completo da fonteZhang, Zhusheng, Qiyuan Bao, Junxiang Wen, Zhuochao Liu, Qi Liu, Yuhui Shen, Lin Shao, Bing Li, Song-An Chen e Weibin Zhang. "Abstract 4545: Integrative immune-genomic comparison of canonical Ewing sarcoma with Ewing-like mimics identifies potential targets for personalized therapies". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 4545. http://dx.doi.org/10.1158/1538-7445.am2023-4545.
Texto completo da fonteLe Deley, Marie-Cecile, Olivier Delattre, Karl-Ludwig Schaefer, Sue A. Burchill, Gabriele Koehler, Pancras C. W. Hogendoorn, Thomas Lion et al. "Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial". Journal of Clinical Oncology 28, n.º 12 (20 de abril de 2010): 1982–88. http://dx.doi.org/10.1200/jco.2009.23.3585.
Texto completo da fonteAnderson, Peter Meade, Luisa-Marie Manning, Brian Rubin, Timothy A. Chan, Scott E. Kilpatrick, Rabi Hanna e Zheng Jin Tu. "Nested set information derived from fusion genes in Ewing sarcoma and other cancers." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junho de 2022): e23521-e23521. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e23521.
Texto completo da fonteFeng, Felix Yi-Chung, Scott Tomlins, Mohammed Alshalalfa, Nicholas Erho, Kasra Yousefi, Shuang Zhao, Robert Benjamin Den et al. "Molecular and clinical characterization of 1,577 primary prostate cancer tumors to reveal novel clinical and biological insights into its subtypes." Journal of Clinical Oncology 33, n.º 7_suppl (1 de março de 2015): 9. http://dx.doi.org/10.1200/jco.2015.33.7_suppl.9.
Texto completo da fonteSmit, F. P., M. Salagierski, D. Hessels, S. A. Jannink e J. A. Schalken. "786 IDENTIFICATION OF ETS GENE FUSIONS USING AFFYMETRIX EXON 1.0 ARRAYS". European Urology Supplements 8, n.º 4 (março de 2009): 317. http://dx.doi.org/10.1016/s1569-9056(09)60774-0.
Texto completo da fonteHammer, Liat, Ryan Rebernick, Matthew McFarlane, Thomas Westbrook, Munna Hazime, Tanya Hammoud, Pin-en Chiu et al. "Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer." Journal of Clinical Oncology 41, n.º 6_suppl (20 de fevereiro de 2023): 263. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.263.
Texto completo da fonteHo, Jen M. Y., Bryan K. Beattie, Jeremy A. Squire, David A. Frank e Dwayne L. Barber. "Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling". Blood 93, n.º 12 (15 de junho de 1999): 4354–64. http://dx.doi.org/10.1182/blood.v93.12.4354.
Texto completo da fonteHo, Jen M. Y., Bryan K. Beattie, Jeremy A. Squire, David A. Frank e Dwayne L. Barber. "Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling". Blood 93, n.º 12 (15 de junho de 1999): 4354–64. http://dx.doi.org/10.1182/blood.v93.12.4354.412k30_4354_4364.
Texto completo da fonteYaseen, Nabeel R., Akiko Takeda, Reza Nazari, Helen Shio, Gunter Blobel e Hualin Zhong. "Carrier-Independent Nuclear Import of the Transcription Factor PU.1." Blood 104, n.º 11 (16 de novembro de 2004): 3561. http://dx.doi.org/10.1182/blood.v104.11.3561.3561.
Texto completo da fonteFeng, F. Y., S. Han, C. Brenner, A. Sabolch, D. A. Hamstra, T. S. Lawrence e A. Chinnaiyan. "PARP inhibition reverses radiation resistance conferred by ETS fusions in prostate cancer." Journal of Clinical Oncology 29, n.º 15_suppl (20 de maio de 2011): 4545. http://dx.doi.org/10.1200/jco.2011.29.15_suppl.4545.
Texto completo da fonteTomlins, Scott A., Anders Bjartell, Arul M. Chinnaiyan, Guido Jenster, Robert K. Nam, Mark A. Rubin e Jack A. Schalken. "ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice". European Urology 56, n.º 2 (agosto de 2009): 275–86. http://dx.doi.org/10.1016/j.eururo.2009.04.036.
Texto completo da fonteDong, Rongfang, Lan Li, Lihua Gong, Mengmeng Tian, Tingting Zhang, Wen Zhang e Yi Ding. "Abstract 2152: Targetable oncogenic fusions and other alterations in bone and soft-tissue tumors assessed by RNA and DNA-based next-generation sequencing in real-world experience". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 2152. http://dx.doi.org/10.1158/1538-7445.am2023-2152.
Texto completo da fonteBilke, Sven, Raphaela Schwentner, Fan Yang, Maximilian Kauer, Gunhild Jug, Robert L. Walker, Sean Davis et al. "Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer". Genome Research 23, n.º 11 (12 de agosto de 2013): 1797–809. http://dx.doi.org/10.1101/gr.151340.112.
Texto completo da fonteTomlins, Scott A., Bharathi Laxman, Saravana M. Dhanasekaran, Beth E. Helgeson, Xuhong Cao, David S. Morris, Anjana Menon et al. "Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer". Nature 448, n.º 7153 (agosto de 2007): 595–99. http://dx.doi.org/10.1038/nature06024.
Texto completo da fonteDehm, Scott M. "Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer". Urologic Oncology: Seminars and Original Investigations 26, n.º 6 (novembro de 2008): 687–88. http://dx.doi.org/10.1016/j.urolonc.2008.09.003.
Texto completo da fonteDong, Jun, Li Xiao, Lu Sheng, Jun Xu e Zhong-Quan Sun. "TMPRSS2:ETS Fusions and Clinicopathologic Characteristics of Prostate Cancer Patients from Eastern China". Asian Pacific Journal of Cancer Prevention 15, n.º 7 (1 de abril de 2014): 3099–103. http://dx.doi.org/10.7314/apjcp.2014.15.7.3099.
Texto completo da fonteDan, Yuqing, Ruibao Ren, Donghe Li e Ping Liu. "Novel Fusion Gene Aven-NUTM1 Induces Mice Myeloid Leukemia Vulnerable to HDAC Inhibitors". Blood 142, Supplement 1 (28 de novembro de 2023): 4123. http://dx.doi.org/10.1182/blood-2023-188034.
Texto completo da fonteCools, Jan, Chrystèle Bilhou-Nabera, Iwona Wlodarska, Christine Cabrol, Pascaline Talmant, Philippe Bernard, Anne Hagemeijer e Peter Marynen. "Fusion of a Novel Gene, BTL, to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)". Blood 94, n.º 5 (1 de setembro de 1999): 1820–24. http://dx.doi.org/10.1182/blood.v94.5.1820.
Texto completo da fonteCools, Jan, Chrystèle Bilhou-Nabera, Iwona Wlodarska, Christine Cabrol, Pascaline Talmant, Philippe Bernard, Anne Hagemeijer e Peter Marynen. "Fusion of a Novel Gene, BTL, to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)". Blood 94, n.º 5 (1 de setembro de 1999): 1820–24. http://dx.doi.org/10.1182/blood.v94.5.1820.417k09_1820_1824.
Texto completo da fonteThompson, Andrew D., Michael A. Teitell, Afsane Arvand e Christopher T. Denny. "Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells". Oncogene 18, n.º 40 (setembro de 1999): 5506–13. http://dx.doi.org/10.1038/sj.onc.1202928.
Texto completo da fonteBraunreiter, Chi L., Jeffery D. Hancock, Cheryl Coffin, Kenneth M. Boucher e Stephen L. Lessnick. "Expression of EWS-ETS Fusions in NIH3T3 Cells Reveals Significant Differences to Ewing’s Sarcoma". Cell Cycle 5, n.º 23 (17 de novembro de 2006): 2753–59. http://dx.doi.org/10.4161/cc.5.23.3505.
Texto completo da fontePaulo, Paula, João D. Barros-Silva, Franclim R. Ribeiro, João Ramalho-Carvalho, Carmen Jerónimo, Rui Henrique, Guro E. Lind, Rolf I. Skotheim, Ragnhild A. Lothe e Manuel R. Teixeira. "FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer". Genes, Chromosomes and Cancer 51, n.º 3 (12 de novembro de 2011): 240–49. http://dx.doi.org/10.1002/gcc.20948.
Texto completo da fonteSeligson, Nathan David, Richard D. Maradiaga, Colin W. Stets, Howard Katzenstein, Sherri Z. Millis, John L. Hays e James Lin Chen. "Multiscale omic assessment of EWSR1-NFATc2 fusion positive sarcomas to identify conserved fusion breakpoint and activation of the mTOR pathway." Journal of Clinical Oncology 38, n.º 15_suppl (20 de maio de 2020): e23536-e23536. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e23536.
Texto completo da fonteGUO, Xiao-Qiang, Yao-Ting GUI e Zhi-Ming CAI. "The progress of TMPRSS2-ETS gene fusions and their mechanism in prostate cancer". Hereditas (Beijing) 33, n.º 2 (5 de maio de 2011): 117–22. http://dx.doi.org/10.3724/sp.j.1005.2011.00117.
Texto completo da fontePflueger, D., S. Terry, A. Sboner, L. Habegger, R. Esgueva, P. C. Lin, M. A. Svensson et al. "Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing". Genome Research 21, n.º 1 (29 de outubro de 2010): 56–67. http://dx.doi.org/10.1101/gr.110684.110.
Texto completo da fonteMiyagi, Yohei, Takeshi Sasaki, Kiyoshi Fujinami, Jinyu Sano, Yutaka Senga, Takeshi Miura, Yoichi Kameda et al. "ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples". Modern Pathology 23, n.º 11 (6 de agosto de 2010): 1492–98. http://dx.doi.org/10.1038/modpathol.2010.149.
Texto completo da fonteXu, Kemin, Alexandra Budhai, Rugved Pattarkine e Minghao Zhong. "Detecting FLI1 Fusion by Immunohistochemistry (IHC) Stain in Prostatic Adenocarcinoma". American Journal of Clinical Pathology 152, Supplement_1 (11 de setembro de 2019): S72—S73. http://dx.doi.org/10.1093/ajcp/aqz113.087.
Texto completo da fonteNakagawa, Hidewaki. "Prostate cancer genomics by high-throughput technologies: genome-wide association study and sequencing analysis". Endocrine-Related Cancer 20, n.º 4 (26 de abril de 2013): R171—R181. http://dx.doi.org/10.1530/erc-13-0113.
Texto completo da fonteMorris, David S., Scott A. Tomlins, Daniel R. Rhodes, Jianjun Yu, Mark A. Rubin, Anders S. Bjartell e Arul M. Chinnaiyan. "OUTLIER EXPRESSION OF SPINK1 IDENTIFIES AN AGGRESSIVE MOLECULAR SUBTYPE IN PROSTATE CANCERS WITHOUT ETS GENE FUSIONS". Journal of Urology 179, n.º 4S (abril de 2008): 707. http://dx.doi.org/10.1016/s0022-5347(08)62060-1.
Texto completo da fonte